Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2014 | 05-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Operating Expenses | 1,271 | 0 | 1,065 | 1,448 | 1,215 |
| Operating Income | -1,271 | 0 | -1,065 | -1,448 | -1,215 |
| Interest Expense | 785 | 0 | 503 | 361 | 323 |
| Other Income | -2,495 | 0 | -257 | 1,940 | 79 |
| Pre-tax Income | -4,551 | 0 | -1,825 | 131 | -1,460 |
| Income Tax | 2 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -4,553 | 0 | -1,825 | 131 | -1,460 |
| Net Income | $-4,553 | $0 | $-1,825 | $131 | $-1,460 |
| EPS Basic Total Ops | -111.11 | N/A | -44.44 | 3.60 | -40.54 |
| EPS Basic Continuous Ops | -111.21 | N/A | -44.39 | 3.54 | -40.53 |
| EPS Diluted Total Ops | -111.11 | N/A | -59.46 | -13.21 | -41.14 |
| EPS Diluted Continuous Ops | -111.21 | N/A | -46.02 | 3.54 | -38.86 |
| EBITDA(a) | $-776 | $0 | $-767 | $-1,280 | $-1,094 |